Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Matawan Pharmaceuticals (Retin-A Manufacturing Unit)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of a medicine for acne vulgaris. The business unit manufactures Retin-A medicinal drug used for the treatment of acne vulgaris.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Cranford, NJ 07016
  • United States

Matawan Pharmaceuticals (Retin-A Manufacturing Unit) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Matawan Pharmaceuticals (Retin-A Manufacturing Unit)‘s full profile, request access.

Request full access to PitchBook

Matawan Pharmaceuticals (Retin-A Manufacturing Unit) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Matawan Pharmaceuticals (Retin-A Manufacturing Unit)‘s full profile, request access.

Request full access to PitchBook